Clinical Trial Update: Safety and Efficacy Study of Investigational Pneumococcal Vaccine in Elderly Population [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing safety and efficacy of an investigational pneumococcal vaccine in the elderly has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Pneumococcal Disease
• Pneumonia

Drugs mentioned

• Investigational pneumococcal vaccine

Snippet

Sponsor: GlaxoSmithKline | Conditions: Prophylaxis Invasive Pneumococcal Diseases and Pneumonia | Phase 2 | Status: COMPLETED